Welcome to LookChem.com Sign In|Join Free
  • or
ABT-279 is a drug compound developed by Abbott Laboratories that functions as a potent and selective inhibitor of the enzyme fatty acid amide hydrolase (FAAH). This enzyme is responsible for the breakdown of endocannabinoids in the body, which are involved in the regulation of pain, mood, and appetite. By inhibiting FAAH, ABT-279 increases the levels of endocannabinoids, potentially leading to therapeutic effects in the treatment of pain, anxiety, and inflammation. ABT-279 has demonstrated promising results in preclinical studies, and ongoing research is exploring its potential as a treatment for various medical conditions.

676559-83-4

Post Buying Request

676559-83-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

676559-83-4 Usage

Uses

Used in Pharmaceutical Industry:
ABT-279 is used as a therapeutic agent for the treatment of pain, anxiety, and inflammation due to its ability to inhibit the enzyme fatty acid amide hydrolase (FAAH), thereby increasing the levels of endocannabinoids in the body. This modulation of endocannabinoid levels can lead to the alleviation of symptoms associated with these conditions.
Used in Pain Management:
ABT-279 is used as a pain management medication to help reduce discomfort and alleviate pain. Its mechanism of action involves inhibiting FAAH, which in turn increases the levels of endocannabinoids that play a role in pain regulation.
Used in Anxiety Treatment:
ABT-279 is used as an anxiolytic medication to help manage anxiety symptoms. By inhibiting FAAH and increasing endocannabinoid levels, it may help to reduce anxiety and promote a sense of well-being.
Used in Inflammation Control:
ABT-279 is used as an anti-inflammatory agent to help control inflammation in the body. The inhibition of FAAH and the subsequent increase in endocannabinoid levels may contribute to the reduction of inflammation and associated symptoms.
Note: The uses listed above are based on the potential therapeutic effects of ABT-279 as described in the provided materials. Further research and clinical trials are necessary to confirm these applications and establish the safety and efficacy of ABT-279 in various medical conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 676559-83-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,6,5,5 and 9 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 676559-83:
(8*6)+(7*7)+(6*6)+(5*5)+(4*5)+(3*9)+(2*8)+(1*3)=224
224 % 10 = 4
So 676559-83-4 is a valid CAS Registry Number.

676559-83-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[4-[[2-[(2S,5R)-2-cyano-5-ethynylpyrrolidin-1-yl]-2-oxoethyl]amino]-4-methylpiperidin-1-yl]pyridine-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names ABT-279

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:676559-83-4 SDS

676559-83-4Upstream product

676559-83-4Downstream Products

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 676559-83-4